Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Front Endocrinol (Lausanne)
2018 Jan 01;9:507. doi: 10.3389/fendo.2018.00507.
Show Gene links
Show Anatomy links
Characterization of NGFFYamide Signaling in Starfish Reveals Roles in Regulation of Feeding Behavior and Locomotory Systems.
Tinoco AB
,
Semmens DC
,
Patching EC
,
Gunner EF
,
Egertová M
,
Elphick MR
.
???displayArticle.abstract???
Neuropeptides in deuterostomian invertebrates that have an Asn-Gly motif (NG peptides) have been identified as orthologs of vertebrate neuropeptide-S (NPS)-type peptides and protostomian crustacean cardioactive peptide (CCAP)-type neuropeptides. To obtain new insights into the physiological roles of NG peptides in deuterostomian invertebrates, here we have characterized the NG peptide signaling system in an echinoderm-the starfish Asterias rubens. The neuropeptide NGFFYamide was identified as the ligand for an A. rubens NPS/CCAP-type receptor, providing further confirmation that NG peptides are orthologs of NPS/CCAP-type neuropeptides. Using mRNA in situ hybridization, cells expressing the NGFFYamide precursor transcript were revealed in the radial nerve cords, circumoral nerve ring, coelomic epithelium, apical muscle, body wall, stomach, and tube feet of A. rubens, indicating that NGFFYamide may have a variety of physiological roles in starfish. One of the most remarkable aspects of starfish biology is their feeding behavior, where the stomach is everted out of the mouth over the soft tissue of prey. Previously, we reported that NGFFYamide triggers retraction of the everted stomach in A. rubens and here we show that in vivo injection of NGFFYamide causes a significant delay in the onset of feeding on prey. To investigate roles in regulating other aspects of starfish physiology, we examined the in vitro effects of NGFFYamide and found that it causes relaxation of acetylcholine-contracted apical muscle preparations and induction of tonic and phasic contraction of tube feet. Furthermore, analysis of the effects of in vivo injection of NGFFYamide on starfish locomotor activity revealed that it causes a significant reduction in mean velocity and distance traveled. Interestingly, experimental studies on mammals have revealed that NPS is an anxiolytic that suppresses appetite and induces hyperactivity in mammals. Our characterization of the actions of NGFFYamide in starfish indicates that NPS/NG peptide/CCAP-type signaling is an evolutionarily ancient regulator of feeding and locomotion.
Figure 1. Feeding behavior of the starfish A. rubens in a laboratory setting. (A) Here a specimen of A. rubens can be seen making contact with a mussel (M. edulis) in an aquarium tank. In experiments reported in this paper, the time elapsed from when the starfish was placed at the opposite end of the tank to the mussel to when the starfish made contact with the mussel (âtime to touchâ) was measured and recorded. (B,C) Here a specimen of A. rubens can be seen enclosing a mussel at the onset of a feeding bout, with photographs taken from a side view (B) and from above (C). In experiments reported in this paper, the time elapsed from when the starfish was placed at the opposite end of the tank to the mussel to when the starfish enclosed the mussel (âtime to encloseâ) was measured and recorded. Scale bars: (A): 2 cm; (B): 2.5 cm; (C): 1.5 cm.
Figure 2. Recording locomotor activity of the starfish A. rubens in a laboratory setting. (A) Photograph of the experimental set-up, with a camera positioned above a Plexiglas aquarium (37 Ã 19.8 Ã 25 cm) containing 7 l of seawater, with all the walls covered with white plastic and situated on top of a lightbox to enhance video contrast, which facilitated detection of the experimental animal by the video-tracking software Ethovision XT1. (B) Photograph showing the software arena settings, with the area defined as the floor in yellow (length of 33 cm) and a starfish positioned in the center of the aquarium at the beginning of an experiment. (C) Photograph showing tracking of a starfish using Ethovision XT1, with the color scale bar representing the time spent in one position (minimum in blue to maximum in red). Scale bars: (A): 13.1 cm; (B): 4.7 cm; (C): 4.7 cm.
Figure 3. Identification of an NPS/CCAP-type receptor in the starfish A. rubens that is activated by the neuropeptide NGFFYamide. (A) Phylogenetic tree showing that the A. rubens NPS/CCAP-type receptor (arrow) is positioned in a clade comprising NPS/CCAP-type receptors that is distinct from a clade comprising paralogous VP/OT-type receptors. Thyrotropin-releasing hormone (TRH)-type receptors were included here as an outgroup. Bootstrap support (1,000 replicates) for each clade is represented with colored stars as denoted in the key. Species in which the ligands for NPS/CCAP-type receptors and/or VP/OT-type receptors have been identified experimentally are shown with red lettering. Species: A. gam (Anopheles gambiae); A. jap (Apostichopus japonicus); A. med (Antedon mediterranea); A. rub (Asterias rubens); B. flo (Branchiostoma floridae); C. tel (Capitella teleta) D. mel (Drosophila melanogaster); E. fet (Eisenia fetida); H. sap (Homo sapiens); L. gig (Lottia gigantea); L. sta (Lymnaea stagnalis); S. kow (Saccoglossus kowalevskii); S. pur (Strongylocentrotus purpuratus); T. cas (Tribolium castaneum). The accession numbers of sequences included in the phylogenetic tree are listed in Supplementary Table 1. (B) Concentration-response curve showing that synthetic NGFFYamide (shown in red) activates the A. rubens NPS/CCAP-type receptor in CHO cells co-expressing the promiscuous G-protein Gα16 and over-expressing the GFP-aequorin fusion protein G5A. Control experiments where CHO cells were transfected with an empty pcDNA 3.1(+) vector are shown in black. Each point (± s.e.m.) represents mean values from at least two independent experiments, with each experiment performed in triplicate. Concentration-response data are shown relative (%) to the maximal response (100% activation) observed in each experiment. The EC50 value for activation of the NPS/CCAP-type receptor with NGFFYamide is 2.1 à 10â13 M.
Figure 4. Localization of NGFFYamide precursor mRNA expression in the nervous system of A. rubens. (A) Transverse section of a radial nerve cord showing stained cells in the epithelium of the ectoneural region, largely concentrated laterally. Note the absence of stained cells in the hyponeural region. The boxed region is shown at a higher magnification in (B), where the elongate, bipolar shape of stained cells (arrowheads) can be seen. (C) Longitudinal section of a radial nerve cord showing stained cells (arrowheads) along the length of the epithelium in the ectoneural region (arrowheads). (D) Stained cells (arrowheads) in the ectoneural epithelium of the circumoral nerve ring. (E) Transverse section of an arm showing stained cells (arrowhead) in the marginal nerve, which is located lateral to the outer row of tube feet on each side of the arm. ec, ectoneural; hy, hyponeural; MN, marginal nerve; TF, tube foot. Scale bars: (A): 33 μm; (B): 16 μm; (C): 16 μm; (D): 33 μm; (E): 16 μm.
Figure 5. Localization of NGFFYamide precursor mRNA expression in the digestive system of A. rubens. (A) Low magnification image showing stained cells (arrowheads) widely distributed in a section of a highly folded aboral region of the cardiac stomach. (B) Stained cells in the cardiac stomach, with the boxed region shown at a higher magnification in (C), where stained cells (arrowheads) can be seen to be located in the mucosal layer or just beneath the basiepithelial nerve plexus. (D) Transverse section of the central disk region showing the cardiac stomach, pyloric stomach, rectal caeca and apical muscle. Stained cells can be seen in the cardiac stomach, pyloric stomach and apical muscle (arrowheads) but not in the rectal caeca. A higher magnification image of expression in the apical muscle is shown in Figure 6E and the boxed region of the pyloric stomach is shown at higher magnification in (E). (F) Stained cells (arrowheads) in a transverse section of a pyloric duct. AM, apical muscle; BNP, basiepithelial nerve plexus; CT, collagenous tissue layer; CS, cardiac stomach; ML, mucosal layer; PS, pyloric stomach; RC, rectal caeca; VML, visceral muscle layer. Scale bars: (A): 33 μm; (B): 16 μm; (C): 6 μm; (D): 33 μm; (E): 16 μm; (F): 16 μm.
Figure 6. Localization of NGFFYamide precursor mRNA expression in the tube feet, apical muscle and body wall of A. rubens. (A) Longitudinal sections of two tube feet, showing stained cells (arrowheads) in the sucker region. (B) Longitudinal sections of three tube feet, with the boxed region shown at higher magnification in (C); here stained cells (arrowhead) can be seen near to the basal nerve ring (*) and in the adhesive region of the tube foot sucker (arrow). (D) Transverse section of an arm showing stained cells (arrowheads) in the coelomic epithelium. (E) Transverse section at the junction between an arm and the central disk showing stained cells (arrowheads) in the coelomic epithelial lining the apical muscle. (F) Transverse section of an arm showing stained cells (arrowheads) in the external epithelium of the body wall. AM, apical muscle; CE, coelomic epithelium; PS, pyloric stomach. Scale bars: (A): 33 μm; (B): 33 μm; (C): 6 μm; (D): 16 μm; (E): 16 μm; (F): 16 μm.
Figure 7. NGFFYamide causes relaxation of in vitro acetylcholine-contracted apical muscle preparations from A. rubens. A representative recording is shown, with 10â6 M NGFFYamide causing transient partial reversal of the contracting action 10â6 M acetylcholine (ACh). Application of ACh and NGFFYamide are labeled with upward pointing arrowheads and washing of the preparation is labeled with a downward pointing arrowhead. The graph shows the mean (± s.e.m.) relaxant effect of NGFFYamide when tested at a concentration of 10â6 M (n = 4).
Figure 8. Application of NGFFYamide to in vitro tube foot preparations from A. rubens triggers phasic contractions that are superimposed upon an increase in basal tone. Representative recordings from a single tube foot preparation are shown, comparing the effect of (A) acetylcholine (ACh; 10â6 M) and the effect of (B) NGFFYamide (10â6 M). Application of ACh and NGFFYamide are labeled with upward pointing arrowheads and washing of the preparation is labeled with a downward pointing arrowhead.
Figure 9. The effects of NGFFYamide in causing both tonic and phasic contraction of tube foot preparations from A. rubens are concentration dependent. (A) Concentration-dependence of the effect of NGFFYamide in causing tonic contraction of tube feet. (B) Concentration-dependence of the effect of NGFFYamide on the peak amplitude of NGFFYamide-induced phasic contractions. (C) Concentration-dependence of the effect of NGFFYamide on the peak frequency of NGFFYamide-induced phasic contractions. The effects of NGFFYamide shown in (A,C) are normalized to the contractile effect observed with 10â6 M Acetylcholine (ACh). Results are expressed as mean ± s.e.m. (n = 6). Different letters indicate statistically significant differences (p < 0.05) by one-way ANOVA (A) or Kruskal-Wallis test (B,C).
Arakane,
Functional analysis of four neuropeptides, EH, ETH, CCAP and bursicon, and their receptors in adult ecdysis behavior of the red flour beetle, Tribolium castaneum.
2008, Pubmed
Arakane,
Functional analysis of four neuropeptides, EH, ETH, CCAP and bursicon, and their receptors in adult ecdysis behavior of the red flour beetle, Tribolium castaneum.
2008,
Pubmed
Beck,
Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats.
2005,
Pubmed
Beets,
Ancient neuromodulation by vasopressin/oxytocin-related peptides.
2013,
Pubmed
Belmont,
Identification of four evolutionarily related G protein-coupled receptors from the malaria mosquito Anopheles gambiae.
2006,
Pubmed
Birenheide,
Peptides controlling stifness of connective tissue in sea cucumbers.
1998,
Pubmed
,
Echinobase
Blowes,
Body wall structure in the starfish Asterias rubens.
2017,
Pubmed
,
Echinobase
Burbach,
What are neuropeptides?
2011,
Pubmed
Cai,
Biochemical, Anatomical, and Pharmacological Characterization of Calcitonin-Type Neuropeptides in Starfish: Discovery of an Ancient Role as Muscle Relaxants.
2018,
Pubmed
,
Echinobase
Camarda,
In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.
2009,
Pubmed
Camilleri,
Neuropeptide S receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders.
2010,
Pubmed
Cazzamali,
Molecular cloning and functional expression of a Drosophila corazonin receptor.
2002,
Pubmed
Chung,
Expression and release patterns of neuropeptides during embryonic development and hatching of the green shore crab, Carcinus maenas.
2004,
Pubmed
Cifani,
Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat.
2011,
Pubmed
Clark,
Neuroendocrine control of larval ecdysis behavior in Drosophila: complex regulation by partially redundant neuropeptides.
2004,
Pubmed
Cline,
Differential appetite-related responses to central neuropeptide S in lines of chickens divergently selected for low or high body weight.
2008,
Pubmed
Cline,
Anorexigenic effects of central neuropeptide S involve the hypothalamus in chicks (Gallus gallus).
2007,
Pubmed
D'Amato,
Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease.
2007,
Pubmed
de Bree,
Structure-function relationships of the vasopressin prohormone domains.
1998,
Pubmed
de Bree,
Trafficking of the vasopressin and oxytocin prohormone through the regulated secretory pathway.
2000,
Pubmed
Domschke,
Neuropeptide S receptor gene -- converging evidence for a role in panic disorder.
2011,
Pubmed
Donini,
Crustacean cardioactive peptide is a modulator of oviduct contractions in Locusta migratoria.
2001,
Pubmed
Duangdao,
Behavioral phenotyping of neuropeptide S receptor knockout mice.
2009,
Pubmed
Edgar,
MUSCLE: multiple sequence alignment with high accuracy and high throughput.
2004,
Pubmed
Elphick,
NG peptides: a novel family of neurophysin-associated neuropeptides.
2010,
Pubmed
,
Echinobase
Elphick,
Nitric Oxide Function in an Echinoderm.
1998,
Pubmed
,
Echinobase
Elphick,
The protein precursors of peptides that affect the mechanics of connective tissue and/or muscle in the echinoderm Apostichopus japonicus.
2012,
Pubmed
,
Echinobase
Elphick,
The SALMFamides: a new family of neuropeptides isolated from an echinoderm.
1991,
Pubmed
,
Echinobase
Elphick,
Evolution of neuropeptide signalling systems.
2018,
Pubmed
Elphick,
NGFFFamide and echinotocin: structurally unrelated myoactive neuropeptides derived from neurophysin-containing precursors in sea urchins.
2009,
Pubmed
,
Echinobase
Elphick,
Distribution and action of SALMFamide neuropeptides in the starfish Asterias rubens.
1995,
Pubmed
,
Echinobase
Endress,
Crustacean cardioactive peptides: Expression, localization, structure, and a possible involvement in regulation of egg-laying in the cuttlefish Sepia officinalis.
2018,
Pubmed
Estévez-Lao,
Cardioacceleratory function of the neurohormone CCAP in the mosquito Anopheles gambiae.
2013,
Pubmed
Fredriksson,
The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.
2003,
Pubmed
Fuse,
Modulation of ecdysis in the moth Manduca sexta: the roles of the suboesophageal and thoracic ganglia.
2002,
Pubmed
Gammie,
Neuropeptide hierarchies and the activation of sequential motor behaviors in the hawkmoth, Manduca sexta.
1997,
Pubmed
Guindon,
New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0.
2010,
Pubmed
Jékely,
Global view of the evolution and diversity of metazoan neuropeptide signaling.
2013,
Pubmed
Jüngling,
Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala.
2008,
Pubmed
Kato,
Neuronal peptides induce oocyte maturation and gamete spawning of sea cucumber, Apostichopus japonicus.
2009,
Pubmed
,
Echinobase
Kim,
Central peptidergic ensembles associated with organization of an innate behavior.
2006,
Pubmed
Kumar,
MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets.
2016,
Pubmed
Li,
Neuropeptide S Increases locomotion activity through corticotropin-releasing factor receptor 1 in substantia nigra of mice.
2015,
Pubmed
Lin,
Functional characterization of a second pedal peptide/orcokinin-type neuropeptide signaling system in the starfish Asterias rubens.
2018,
Pubmed
,
Echinobase
Lin,
Pedal peptide/orcokinin-type neuropeptide signaling in a deuterostome: The anatomy and pharmacology of starfish myorelaxant peptide in Asterias rubens.
2017,
Pubmed
,
Echinobase
Mayorova,
Localization of Neuropeptide Gene Expression in Larvae of an Echinoderm, the Starfish Asterias rubens.
2016,
Pubmed
,
Echinobase
Meis,
Identification of a neuropeptide S responsive circuitry shaping amygdala activity via the endopiriform nucleus.
2008,
Pubmed
Melarange,
Comparative analysis of nitric oxide and SALMFamide neuropeptides as general muscle relaxants in starfish.
2003,
Pubmed
,
Echinobase
Mikani,
Brain-midgut cross-talk and autocrine metabolastat via the sNPF/CCAP negative feed-back loop in the American cockroach, Periplaneta americana.
2015,
Pubmed
Mirabeau,
Molecular evolution of peptidergic signaling systems in bilaterians.
2013,
Pubmed
Moore,
Immunocytochemical mapping of the novel echinoderm neuropeptide SALMFamide 1 (S1) in the starfish Asterias rubens.
1993,
Pubmed
,
Echinobase
Niimi,
Centrally administered neuropeptide S activates orexin-containing neurons in the hypothalamus and stimulates feeding in rats.
2006,
Pubmed
Okamura,
Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor.
2008,
Pubmed
Okamura,
Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder.
2007,
Pubmed
Pañeda,
Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice.
2009,
Pubmed
Park,
Identification of G protein-coupled receptors for Drosophila PRXamide peptides, CCAP, corazonin, and AKH supports a theory of ligand-receptor coevolution.
2002,
Pubmed
Park,
Targeted ablation of CCAP neuropeptide-containing neurons of Drosophila causes specific defects in execution and circadian timing of ecdysis behavior.
2003,
Pubmed
Peng,
Central Neuropeptide S inhibits food intake in mice through activation of Neuropeptide S receptor.
2010,
Pubmed
Phlippen,
Ecdysis of decapod crustaceans is associated with a dramatic release of crustacean cardioactive peptide into the haemolymph.
2000,
Pubmed
Protas,
The effects of some transmitter substances of the tube foot muscles of the starfish, Asterias amurensis (Lütken).
1980,
Pubmed
,
Echinobase
Pulkkinen,
Neuropeptide S and G protein-coupled receptor 154 modulate macrophage immune responses.
2006,
Pubmed
Reinscheid,
Phylogenetic appearance of neuropeptide S precursor proteins in tetrapods.
2007,
Pubmed
Rizzi,
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice.
2008,
Pubmed
Roth,
Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation.
2006,
Pubmed
Sakai,
Characterization of crustacean cardioactive peptide as a novel insect midgut factor: isolation, localization, and stimulation of alpha-amylase activity and gut contraction.
2004,
Pubmed
Sakai,
Nutrient-induced alpha-amylase and protease activity is regulated by crustacean cardioactive peptide (CCAP) in the cockroach midgut.
2006,
Pubmed
Semmens,
Discovery of a novel neurophysin-associated neuropeptide that triggers cardiac stomach contraction and retraction in starfish.
2013,
Pubmed
,
Echinobase
Semmens,
Discovery of sea urchin NGFFFamide receptor unites a bilaterian neuropeptide family.
2015,
Pubmed
,
Echinobase
Smith,
Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake.
2006,
Pubmed
Stangier,
Unusual cardioactive peptide (CCAP) from pericardial organs of the shore crab Carcinus maenas.
1987,
Pubmed
Tian,
Functional Characterization of Paralogous Gonadotropin-Releasing Hormone-Type and Corazonin-Type Neuropeptides in an Echinoderm.
2017,
Pubmed
,
Echinobase
Valsalan,
Evolutionary history of the neuropeptide S receptor/neuropeptide S system.
2014,
Pubmed
van den Pol,
Neuropeptide transmission in brain circuits.
2012,
Pubmed
Vehovszky,
Crustacean cardioactive peptide (CCAP)-related molluscan peptides (M-CCAPs) are potential extrinsic modulators of the buccal feeding network in the pond snail Lymnaea stagnalis.
2005,
Pubmed
Vitale,
Anxiolytic-like effect of neuropeptide S in the rat defensive burying.
2008,
Pubmed
Wan Saudi,
Neuropeptide S reduces duodenal bicarbonate secretion and ethanol-induced increases in duodenal motility in rats.
2017,
Pubmed
Xu,
Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects.
2004,
Pubmed
Yañez-Guerra,
Discovery and functional characterisation of a luqin-type neuropeptide signalling system in a deuterostome.
2018,
Pubmed
,
Echinobase
Zandawala,
Discovery of novel representatives of bilaterian neuropeptide families and reconstruction of neuropeptide precursor evolution in ophiuroid echinoderms.
2017,
Pubmed
,
Echinobase
Zitnan,
Excitatory and inhibitory roles of central ganglia in initiation of the insect ecdysis behavioural sequence.
2000,
Pubmed